|
||||||||||||||||||||||
|
|
Alternate Title Phase III Randomized Study of an Electronic Tool for Monitoring Symptoms and Syndromes Associated With Advanced Cancer (E-MOSAIC) in Patients With Advanced Incurable Cancer Receiving Palliative Anticancer Treatment
Trial Description A hand held electronic tool used to monitor symptoms and assess quality of life may improve communication between patients and their doctors and improve the ability to plan treatment for patients with advanced cancer receiving palliative care. It is not yet known whether symptoms are better controlled with or without use of this electronic tool. This randomized phase III trial is studying an electronic tool to see how well it records cancer symptoms in patients with advanced cancer receiving palliative care. Eligibility criteria include the following:
Final eligibility for a clinical trial is determined by the health professionals conducting the trial. Doctors and their patients will be randomly assigned (have an equal chance of being placed) to one of two groups. In group one, patients will use a hand held electronic tool once a week to record information about their symptoms and diet. Nurses will record the patient’s weight and Karnofsky performance status once a week. Information from the hand held electronic tool will be printed and stored. In group two, patients will use a hand held electronic tool once a week to rate specific symptoms, including pain, fatigue, drowsiness, nausea, anxiety, depression, shortness of breath, loss of appetite, overall well-being, other symptoms, and diet. Nurses will record the patient’s weight, Karnofsky performance status, body mass index, and use of medications for pain, fatigue, anorexia, or weight loss once a week. Information from the hand held electronic tool will be printed and stored. In both groups, patients will be evaluated at the beginning of the study and at 3 and 6 weeks. Important: For more details about this trial, refer to the Health Professional version of the trial summary. If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site. Trial Lead Organizations Swiss Group for Clinical Cancer Research
|
NCI Home |
Images Version |
Contact Us |
Policies |
Accessibility |
Viewing Files |
FOIA |
Site Help |
Site Map
|
A Service of the National Cancer Institute |